PolyPeptide Group AG provided earnings guidance for the year 2023. For the year, in terms of revenues, mid to high single-digit percentage versus 2022. So that will be 4% to 9% growth.

Excluding COVID-19 revenues, this full year guidance equates to 25% to 32% growth. The company is targeting a net loss for 2023.